Skip to main content

Lynch Syndrome

2
Pipeline Programs
6
Companies
5
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

Sofie
SofieVA - Dulles
1 program
1
MesalaminePhase 21 trial
Active Trials
NCT04920149Recruiting150Est. Sep 2045
Medtronic
MedtronicNJ - Phillipsburg
1 program
1
Capsule endoscopyPhase 11 trial
Active Trials
NCT00898768Completed200Est. Dec 2014
FUJIFILM Pharma
FUJIFILM PharmaMA - Cambridge
1 program
ColonoscopyN/A1 trial
Active Trials
NCT03344289Completed357Est. Jun 2020
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Let's Talk Genetics ProvidersN/A1 trial
Active Trials
NCT07304063Not Yet Recruiting20Est. Oct 2026
Genome & Company
Genome & CompanyKorea - Suwon
1 program
Let's Talk Genetics ProvidersN/A
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
Lynch Syndrome Integrative Epidemiology and GeneticsN/A1 trial
Active Trials
NCT06582914Recruiting5,000Est. Dec 2054

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
SofieMesalamine
MedtronicCapsule endoscopy
Human BioSciencesLet's Talk Genetics Providers
Colorado TherapeuticsLynch Syndrome Integrative Epidemiology and Genetics
FUJIFILM PharmaColonoscopy

Clinical Trials (5)

Total enrollment: 5,727 patients across 5 trials

NCT04920149SofieMesalamine

Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome

Start: Mar 2022Est. completion: Sep 2045150 patients
Phase 2Recruiting
NCT00898768MedtronicCapsule endoscopy

Capsule Endoscopy to Screen for Small Bowel Neoplasia in Lynch Syndrome

Start: May 2009Est. completion: Dec 2014200 patients
Phase 1Completed
NCT07304063Human BioSciencesLet's Talk Genetics Providers

Overcoming Barriers to Uptake of Cascade Screening

Start: May 2026Est. completion: Oct 202620 patients
N/ANot Yet Recruiting
NCT06582914Colorado TherapeuticsLynch Syndrome Integrative Epidemiology and Genetics

Lynch Syndrome Integrative Epidemiology and Genetics

Start: Oct 2024Est. completion: Dec 20545,000 patients
N/ARecruiting
NCT03344289FUJIFILM PharmaColonoscopy

Linked Color Imaging Versus High-definition White Light Endoscopy for the Detection of Polyps in Patients With Lynch Syndrome (LCI-LYNCH)

Start: Jan 2018Est. completion: Jun 2020357 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 5,727 patients
6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.